Reference Source

61703-150-05 · Carboplatin Injection · Hospira, Inc., a Pfizer Company

What is the package ndc for 61703-150-05 · Carboplatin Injection · Hospira, Inc., a Pfizer Company?

For 61703-150-05 · Carboplatin Injection · Hospira, Inc., a Pfizer Company, package ndc is 61703-150-05; generic name is Carboplatin Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-15.

"initial_posting_date": "04/28/2023", "package_ndc": "61703-150-05", "generic_name": "Carboplatin Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay"

api.fda.gov, retrieved 2026-09-01

Package NDC
61703-150-05 verified
Generic name
Carboplatin Injection verified
Manufacturer
Hospira, Inc., a Pfizer Company verified
Status
Current verified
Availability now
Unavailable verified
FDA note
Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay verified
Initial posting date
04/28/2023 verified
Last update date
08/24/2026 verified
Days in shortage
1222 our reading
Reason for shortage
Other verified
Dosage form
Injection verified
Therapeutic category
Oncology verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "08/24/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

— all from api.fda.gov, retrieved 2026-09-01

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.